Agarwal Ritesh, Muthu Valliappan, Sehgal Inderpaul Singh, Dhooria Sahajal, Prasad Kuruswamy Thurai, Soundappan Kathirvel, Rudramurthy Shivaprakash Mandya, Aggarwal Ashutosh Nath, Chakrabarti Arunaloke
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
Diagnostics (Basel). 2023 Mar 1;13(5):922. doi: 10.3390/diagnostics13050922.
: The prevalence of aspergillus sensitization (AS) and allergic bronchopulmonary aspergillosis (ABPA) in asthmatic children remains unclear. : To systematically review the literature to estimate the prevalence of AS and ABPA in children with bronchial asthma. : We searched the PubMed and Embase databases for studies reporting the prevalence of AS or ABPA in pediatric asthma. The primary outcome was to assess the prevalence of AS, while the secondary outcome was to evaluate the prevalence of ABPA. We pooled the prevalence estimates using a random effects model. We also calculated the heterogeneity and publication bias. : Of the 11,695 records retrieved, 16 studies with 2468 asthmatic children met the inclusion criteria. Most studies were published from tertiary centers. The pooled prevalence of AS in asthma (15 studies; 2361 subjects) was 16.1% (95% confidence intervals [CI], 9.3-24.3). The prevalence of AS was significantly higher in prospective studies, studies from India, and those from developing countries. The pooled prevalence of ABPA in asthma (5 studies; 505 children) was 9.9% (95% CI, 0.81-27.6). There was significant heterogeneity and publication bias for both outcomes. : We found a high prevalence of AS and ABPA in asthmatic children. There is a need for community-based studies from different ethnicities using a standard methodology to ascertain the true prevalence of AS and ABPA in pediatric asthma.
哮喘儿童中曲霉致敏(AS)和变应性支气管肺曲霉病(ABPA)的患病率仍不清楚。
为了系统回顾文献以估计支气管哮喘儿童中AS和ABPA的患病率。
我们在PubMed和Embase数据库中检索了报告小儿哮喘中AS或ABPA患病率的研究。主要结局是评估AS的患病率,次要结局是评估ABPA的患病率。我们使用随机效应模型汇总患病率估计值。我们还计算了异质性和发表偏倚。
在检索到的11,695条记录中,有16项研究共2468名哮喘儿童符合纳入标准。大多数研究来自三级中心。哮喘中AS的汇总患病率(15项研究;2361名受试者)为16.1%(95%置信区间[CI],9.3-24.3)。在前瞻性研究、来自印度的研究以及来自发展中国家的研究中,AS的患病率明显更高。哮喘中ABPA的汇总患病率(5项研究;505名儿童)为9.9%(95%CI,0.81-27.6)。两个结局均存在明显的异质性和发表偏倚。
我们发现哮喘儿童中AS和ABPA的患病率很高。需要采用标准方法开展基于不同种族的社区研究,以确定小儿哮喘中AS和ABPA的真实患病率。